Dianthus Therapeutics, Inc. /DE/ Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2017 to Q4 2023.
  • Dianthus Therapeutics, Inc. /DE/ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2023 was $73.6M, a 1267% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $73.6M +$68.2M +1267% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $5.38M +$732K +15.7% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $4.65M -$45.3M -90.7% Dec 31, 2021 8-K 2023-12-21
Q4 2020 $50M +$29.1M +140% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $20.8M +$9.73M +87.6% Dec 31, 2019 10-K 2021-03-03
Q4 2018 $11.1M +$5.95M +115% Dec 31, 2018 10-K 2020-03-03
Q4 2017 $5.16M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.